Nitric oxide and fetal organ blood flow during normoxia and hypoxemia in endotoxin-treated fetal sheep.
OBJECTIVE
To investigate the role of nitric oxide in the process of circulatory decentralization during fetal hypoxemia.


METHODS
Fifteen sheep with singleton pregnancies were chronically instrumented at 107 days of gestation (term is 147 days). Three days later, 8 of the fetuses received nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthesis. Fifteen minutes after L-NAME administration, all 15 fetuses received lipopolysaccharides (LPS) from a strain of Escherichia coli. The 7 fetuses that received LPS only were used as controls. Sixty minutes after LPS was administered, the maternal aorta was occluded for 2 minutes in all fetuses. Organ blood flow and physiological variables were measured at 75 minutes before the start of occlusion (ie, at the time of L-NAME administration to the experimental group), at 1 minute before the start of occlusion, and at 2, 4, and 30 minutes after the start of occlusion.


RESULTS
Arterial pH was lower in the L-NAME group than in the control group at 1 minute before and 2 minutes after occlusion. Mean arterial pressure was higher in the L-NAME group than in the control group at 2 and 4 minutes after occlusion. Cardiac output fell in the L-NAME group and was lower than in the control group; the percentage of cardiac output to the cerebrum in the L-NAME group was 35% lower than that in the control group. Throughout the study, placental blood flow decreased by more than 80% in both groups and remained low. Blood flow to the fetal body decreased by 65% in the L-NAME group and was lower than in the control group. Blood flow to the carcass also decreased in the L-NAME group and was 36% of that in the control group.


CONCLUSIONS
Inhibition of nitric oxide synthesis causes a general vasoconstriction in practically all organs and leads to a reduction in LPS-induced circulatory decentralization. The changes in blood flow distribution in endotoxin-treated fetal sheep seem to be mediated in part by nitric oxide.
Coumans
Audrey B C
AB
Department of Obstetrics and Gynecology, University of Maastricht, Maastricht, The Netherlands.
Garnier
Yves
Y
Supçun
Sirma
S
Jensen
Arne
A
Berger
Richard
R
Hasaart
Tom H M
TH
D000818:Animals; D001783:Blood Flow Velocity; D002302:Cardiac Output; D019446:Endotoxemia / Q000503:physiopathology*; D004731:Endotoxins / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004926:Escherichia coli; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005318:Fetal Heart / Q000503:physiopathology; D005311:Fetal Hypoxia / Q000503:physiopathology*; D005333:Fetus / Q000098:blood supply*; D008070:Lipopolysaccharides / Q000008:administration & dosage; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000502:physiology*; D011247:Pregnancy; D012039:Regional Blood Flow; D012756:Sheep; D014655:Vascular Resistance; D014664:Vasodilation
D004731:Endotoxins; D004791:Enzyme Inhibitors; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D019331:NG-Nitroarginine Methyl Ester